SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly shares are experiencing volatility as investors react to competitive data in the GLP-1 sector and positive clinical trial readouts for the company's oncology pipeline. While the community remains divided over the sustainability of its premium valuation, bullish sentiment persists around the anticipated regulatory approval of its oral obesity therapy.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer Inc. is experiencing extreme volatility and heavy investor interest following its recent public debut, driven by its specialized focus on AI-driven autonomous drone software already deployed in active combat zones. Market participants are actively debating the stock's potential for a massive short-term run due to its micro-float structure, with discussions polarized between excitement over its defense-tech relevance and skepticism regarding its early-stage revenue and valuation.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology is facing significant volatility ahead of its upcoming earnings report, with the community actively debating whether the recent share price decline presents a compelling buying opportunity or a signal of broader weakness. Investors are closely monitoring how the company's copper and optical interconnect technologies will hold up against evolving hyperscaler demands and competitive pressures from peers.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting Carriers with Shippers on its platform, and gives Carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is trending as investors digest a series of strategic pivots, including the acquisition of parking app SpotHero and the launch of 'Uber Autonomous Solutions' to court robotaxi developers. While some in the community express skepticism over heavy R&D spending and long-term viability, others view these movescoupled with significant insider buying by the CFOas a strong signal that the company is effectively positioning itself as the central, asset-light marketplace for future autonomous mobility.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is gaining attention as investors react to long-term clinical data published in JAMA Neurology, which reinforces the efficacy and durability of Briumvi in treating relapsing multiple sclerosis. The community remains focused on the company's revenue growth trajectory, potential for a buyout, and the strategic impact of its new national awareness campaign.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is currently a focal point for investors as it approaches critical mid-year regulatory deadlines, with community discourse heavily influenced by a mix of milestone euphoria surrounding nuclear design approvals and anxiety over the company's pre-revenue financial status. Market participants are intensely debating the stock's volatility ahead of earnings, tracking heavy options activity and insider trading patterns while weighing the company's long-term potential as a power source for AI infrastructure against the reality of its speculative business model.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is trending due to a major hyperscale customer order for 1.6T data center transceivers, fueling intense speculation about the company's role in future AI infrastructure. While bulls are celebrating strong momentum and aggressive price target upgrades, the community remains deeply divided, with bears pointing to massive insider selling and historical volatility as signs of an impending correction.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors monitor the upcoming deadline for a potential proxy fight involving major shareholder Shah Capital, while simultaneously tracking key institutional conferences and high short interest. The community is actively debating the impact of upcoming data, the potential for new high-value licensing partnerships, and the stock's positioning against struggling mRNA competitors.

Elbit Systems Ltd. engages in the defense and homeland security sector. It develops and supplies airborne, land and naval systems and products for defense, homeland security, and commercial applications. The firm also provides training and support services. The company was founded in 1996 and is headquartered in Haifa, Israel.

Elbit Systems Ltd.

Elbit Systems is trending as investors monitor ongoing contract wins in the global defense sector, while community discussions focus on its technical performance and valuation compared to industry peers. Market participants are also weighing the impact of its recent dividend increase and elevated demand for military technologies against a backdrop of regional geopolitical volatility.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) continues to see massive volatility as investors weigh the rapid adoption of USDC against institutional insider selling and competitive threats in the stablecoin market. The community remains deeply divided, with bulls pointing to growing transaction volumes and strategic partnerships, while vocal bears argue that the stock's recent parabolic rise is a detached, synthetic rally prone to a sharp reversal.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Citi’s CFO in the earnings call this month had said that he expects to see headcount continue to trend downward.</li><li>Citigroup is reportedly expected to lay off more employees in March following a round of 1000 job cuts this month.&nbsp;</li><li>The new round of layoffs is expected to be announced after bonuses are paid, a report from Reuters News said.</li></ul>Citigroup will continue to cut more jobs in 2026, as part of its CEO’s reorganization efforts, a company spokesperson told Stocktwits on Thursday.&nbsp;“We will continue to reduce our headcount in 2026,” a company spokesperson said in an emailed response to Stocktwits’ query.&nbsp;“These changes reflect adjustments we’re making to ensure our staffing levels, locations and expertise align with current business needs; efficiencies we have gained through technology; and progress against our Transformation work, which is nearing target state,” the spokesperson added.&nbsp;Shares in the company were down 1.7% at the time of writing.&nbsp;<h2 class="st-heading-2">Cuts In March</h2>Citigroup is reportedly expected to lay off more employees in March following a round of 1,000 job cuts this month.&nbsp;The new round of layoffs is expected to be announced after bonuses are paid, a report from Reuters News said, citing sources familiar with the matter.&nbsp;The March layoffs are likely to affect managing directors and senior employees across business lines and some senior managers have already been reassigned to different divisions to secure roles before headcount is reduced, the report added.&nbsp;<h2 class="st-heading-2">CEO’s Reorganization Efforts</h2>Citi’s CEO Jane Fraser has led the corporate reorganization efforts at the U.S. firm since taking up the role, in a bid to trim down management layers and fasten decision making.Citi’s Chief Financial Officer Mark Mason during its fourth quarter earnings call said that Citi's workforce shrank by 20,000 since 2022 and is now at 226,000 employees by the end of 2025.“We'll see that cost and headcount come down as we continue to improve productivity and implement tools like AI, we'd see an impact, or expect to see an impact on headcount. So, notwithstanding, insourcing and driving broader efficiency, I would expect to see headcount continue to trend downward,” he had said.&nbsp;<h2 class="st-heading-2">Recent Earnings</h2>Citi reported higher fourth quarter (Q4) profit buoyed by rebound in dealmaking activities, that beat analyst estimates. On an adjusted basis, Citi reported a ​profit of $1.81 per share during the quarter, compared with analysts' average estimate of $1.67, according to data from fiscal.ai.&nbsp;Citi’s investment banking fees in Q4 rose 35% to $1.29 billion, up from $951 million from a year-ago quarter.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment around Citi trended in ‘bearish’ territory amid ‘low’ message volume.&nbsp;Shares in the bank have risen 39% over the past 12 months.&nbsp; &nbsp;

A Citibank logo is displayed outside their bank on February 28, 2025 in San Diego, California. (Photo by Kevin Carter/Getty Images)

Citi Will Cut More Jobs In 2026 As Part Of CEO’s Reorganization Efforts

A Citigroup spokesperson told Stocktwits that layoffs reflect adjustments Citi is making to ensure its staffing levels, locations and expertise align with current business needs. 

Equity

A Citigroup spokesperson told Stocktwits that layoffs reflect adjustments Citi is making to ensure its staffing levels, locations and expertise align with current business needs. 


<ul class="summary-bullets"><li>“We will continue to reduce our headcount in 2026”, the company said, as per the report.&nbsp;</li><li>CEO Jane Fraser has taken the corporate reorganization efforts at the U.S. firm since taking up the role</li><li>Citigroup is planning to report results on Wednesday and inform its staff of their bonuses for 2025. &nbsp;</li></ul>U.S. banking giant Citigroup is reportedly cutting 1000 jobs this week as part of its CEO Jane Fraser's cost-cutting efforts.The job cuts are part of the bank's plan announced two years ago to reduce staff by 20,000 before the end of 2026, according to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2026-01-12/citi-to-cut-about-1-000-jobs-this-week-as-fraser-trims-costs">report</a> from Bloomberg News that cited people familiar with the matter.&nbsp;Fraser has taken the corporate reorganization efforts at the U.S. firm since taking up the role, in a bid to trim down management layers and fasten decision making.&nbsp;“We will continue to reduce our headcount in 2026”, the company said, as per the report. It further added that these changes reflect adjustments the company is making to ensure staffing levels and expertise align with current business needs.&nbsp;<h2 class="st-heading-2">FY25 Results On The Horizon</h2>Citigroup is planning to report results on Wednesday and inform its staff of their bonuses for 2025.&nbsp;The company is expected to post a revenue of $20.5 billion for the fourth quarter (Q4) as per the data from Fiscal.ai. It is also expected to post a profit of $1.73 per share.&nbsp;<h2 class="st-heading-2">Improving Control Issues</h2>Citigroup has been improving its oversight and control deficiencies in its business. Last month, the Federal Reserve told the firm that it has closed formal notices requiring the bank to fix trading risk management weaknesses, according to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/sustainability/boards-policy-regulation/us-fed-terminates-citi-notices-that-demanded-bank-improve-risk-controls-sources-2025-12-17/">report</a> from Reuters News.The Fed in 2023 had issued notices to Citi to address three so-called Matters Requiring Immediate Attention, or MRIAs, identifying problems relating to how the bank calculates and manages the risks of its trading partners and sets aside capital to cushion potential losses on those trades, the report added.&nbsp;<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment around <a href="https://stocktwits.com/symbol/C">C</a> trended in ‘neutral’ territory amid ‘high’ message volume.&nbsp;Shares in Citigroup have risen nearly 66% over the past year.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

Chief executive officer of Citigroup Jane Fraser visits FOX Business Network's "Mornings With Maria" at Fox Business Network Studios on May 29, 2025 in New York City. (Photo by John Lamparski/Getty Images)

US Banking Giant Citigroup To Cut 1,000 Jobs This Week: Report

The job cuts are part of the bank's plan announced two years ago to reduce staff by 20,000 before the end of 2026, Bloomberg News report said. 

<ul class="summary-bullets"><li>Piper Sandler downgraded ALEX stock to ‘Neutral’ from ‘Overweight’ and kept the price target unchanged at $21.</li><li>Alexander &amp; Baldwin announced on Monday that it would go private in a deal worth $2.3 billion.&nbsp;</li><li>The company will be acquired by a MW Group joint venture for $21.20 per share by the first quarter of 2026, the company said in a statement.&nbsp; &nbsp;</li></ul>Shares of Alexander &amp; Baldwin (ALEX) rallied over 38% on Tuesday morning after the announcement of the $2.3 billion take-private deal.The company’s outstanding shares will be acquired at $21.20 per share by a joint venture formed among MW Group, Blackstone Real Estate, and DivcoWest, expected to close by the first quarter of 2026. The all-cash deal represents a 40% premium to the company’s closing price as of Dec. 8, 2025.&nbsp;In addition, Alexander &amp; Baldwin announced a fourth-quarter (Q4) 2025 dividend of $0.35 per share, payable on January 8, 2026.&nbsp;<h2 class="st-heading-2">Street Action</h2>Meanwhile, Piper Sandler downgraded ALEX to ‘Neutral’ from ‘Overweight’ before, while keeping the price target intact at $21, as cited on TheFly. Piper said that it has revised its rating following the announcement and does not expect a competing bid to emerge.“Today, we are taking an important step toward our long-term vision for A&amp;B as stewards of Hawai'i's premier commercial real estate. As a private company supported by the deep real estate expertise and experience of our new ownership group, A&amp;B will have greater capacity to serve its tenants and communities,” President and CEO Lance Parker said.&nbsp;Alexander &amp; Baldwin is the only publicly traded real estate investment trust focused solely on Hawaiian commercial real estate. The company owns about four million square feet of commercial space in Hawai'i.&nbsp;<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around ALEX jumped from ‘neutral’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:1276/154;" src="https://news.stocktwits-cdn.com/Screenshot_2025_12_09_at_8_30_30_PM_png_5f7959ea10.webp" alt="On Stocktwits, retail sentiment around ALEX jumped from ‘neutral’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels." width="1276" height="154"></figure>Shares of ALEX have climbed over 18% in the past year and returned almost 30% in the last five years.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com&nbsp;

Generic Image of Office Space (Photo by Fairfax Media via Getty Images via Getty Images)

Alexander & Baldwin Shares Shoot Through The Roof After $2.3B Take Private Deal – This Firm Has Downgraded The Stock

Shares of ALEX surged over 38% in pre-market trading while Piper Sandler downgraded the stock. 

Teva Pharmaceuticals, the U.S. affiliate of Teva Pharmaceutical Industries (TEVA), announced on Thursday that the U.S. Food and Drug Administration has approved a generic version of the Liraglutide injection known as Saxenda.Liraglutide Injection is a glucagon-like peptide 1 (GLP-1) receptor agonist indicated to reduce excess body weight and maintain weight reduction long-term in adults as well as pediatric patients aged 12 years and older with body weight greater than 60 kg and obesity. The drug is to be used in combination with a reduced-calorie diet and increased physical activity.“With this approval, and by launching a generic for Saxenda (liraglutide injection), we will provide patients in the U.S. the first ever generic GLP-1 product specifically indicated for weight loss,” <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-approval-and-launch-of-generic-saxenda-liraglutide-injection--first-generic-glp-1-/">said</a> Ernie Richardsen, Head of U.S. Commercial Generics at Teva. He added that it marks an important addition to the company’s generics portfolio.Saxenda, Novo Nordisk’s older obesity drug, had annual sales of $165 million as of June 2025, the company said. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/TEVA">TEVA stock</a> trended within ‘neutral’ territory over the past 24 hours, while message volume remained at ‘high’ levels.<figure class="image"><img style="aspect-ratio:625/64;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_28_at_9_52_29_AM_png_ba7ec14e95.webp" alt="TEVA's Sentiment Meter and Message Volume as of 9:52 a.m. ET on Aug. 28, 2025 | Source: Stocktwits" width="625" height="64"><figcaption>TEVA's Sentiment Meter and Message Volume as of 9:52 a.m. ET on Aug. 28, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user expressed surprise that the stock is not trading higher despite the approval.<stembedurl>https://stocktwits.com/RemitTekram/message/626845403</stembedurl>Another user sounded skeptical, saying that the stock would probably end the day in the red despite “explosive news.”<stembedurl>https://stocktwits.com/NoTradeAnymore/message/626842741</stembedurl>In the second quarter, Teva recorded revenue of $4.2 billion and adjusted and diluted earnings per share of $0.66. Generics product revenues in the U.S., however, fell 6% to $961 million, due to lower revenues from Lenalidomide capsules, the generic version of Revlimid, and Liraglutide injection 1.8mg, an authorized generic of Victoza, primarily driven by increased competition.TEVA stock is down 19% this year and approximately 3% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/lakeshore-biopharma-receives-revised-proposal-to-acquire-company/chs6JRRRdmm">LakeShore Biopharma Receives Revised Proposal To Acquire Company</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

A very overweight woman with swollen feet stands on a scale that reads 145.1 kilograms. Overweight and obesity are increasing at a rapid pace worldwide. Photo: Pia Bayer/dpa (Photo by Pia Bayer/picture alliance via Getty Images)

This Pharma Stock Is Down 19% In 2025 But Just Received An ‘Explosive News’ – Find Out More

The company’s U.S. affiliate announced that the U.S. Food and Drug Administration has approved a generic version of Liraglutide injection, known as Saxenda.

IYLD
iShares Morningstar Multi-Asset Income ETF

Feed

News

Sentiment

Fundamentals

Info

Latest IYLD News

IYLDiShares Morningstar Multi-Asset Income ETF